Efficacy and safety of new direct oral anticoagulants in chronic kidney disease: AHA 2019 updated guidelines and review of the literature

Efficacy and safety of new direct oral anticoagulants in chronic kidney disease: AHA 2019 updated guidelines and review of the literature

Direct oral anticoagulants (DOACs) are the drug of choice for the treatment of atrial fibrillation-associated systemic embolism and reducing the risk of strokes in chronic kidney disease (CKD) patients. DOACs have fewer drug-to-drug interactions as well as fewer side effects, compared to warfarin. T...

Full description

Bibliographic Details
Main Authors: Hubert Stępak, Zbigniew Krasiński, Andrzej Jawień, Navid Ahmadi, Adam Lipowski, Michał Stanisic
Format: Article
Language:English
Published: Termedia Publishing House 2020-01-01
Series:Polish Journal of Thoracic and Cardiovascular Surgery
Subjects:
direct oral anticoagulants
chronic kidney disease
Online Access:https://www.termedia.pl/Efficacy-and-safety-of-new-direct-oral-anticoagulants-in-chronic-kidney-disease-AHA-2019-updated-guidelines-and-review-of-the-literature,40,39480,1,1.html

Internet

https://www.termedia.pl/Efficacy-and-safety-of-new-direct-oral-anticoagulants-in-chronic-kidney-disease-AHA-2019-updated-guidelines-and-review-of-the-literature,40,39480,1,1.html

Similar Items